ultomiris
alexion europe sas - ravulizumab - hemoglobinuria, paroksysmal - selektywne leki immunosupresyjne - paroxysmal nocturnal haemoglobinuria (pnh)ultomiris is indicated in the treatment of adult and paediatric patients with a body weight of 10 kg or above with pnh:- in patients with haemolysis with clinical symptom(s) indicative of high disease activity. - in patients who are clinically stable after having been treated with eculizumab for at least the past 6 months (see section 5. atypical haemolytic uremic syndrome (ahus)ultomiris is indicated in the treatment of patients with a body weight of 10 kg or above with ahus who are complement inhibitor treatment-naïve or have received eculizumab for at least 3 months and have evidence of response to eculizumab (see section 5. generalized myasthenia gravis (gmg)ultomiris is indicated as an add-on to standard therapy for the treatment of adult patients with gmg who are anti-acetylcholine receptor (achr) antibody-positive. neuromyelitis optica spectrum disorder (nmosd)ultomiris is indicated in the treatment of adult patients with nmosd who are anti-aquaporin 4 (aqp4) antibody-positive (see section 5. ultomiris is indicated in the treatment of adult patients with paroxysmal nocturnal haemoglobinuria (pnh):- in patients with haemolysis with clinical symptom(s) indicative of high disease activity. - in patients who are clinically stable after having been treated with eculizumab for at least the past 6 months. ultomiris is indicated in the treatment of adult patients with atypical haemolytic uremic syndrome (ahus) who are complement inhibitor treatment-naïve or have received eculizumab for at least 3 months and have evidence of response to eculizumab.
aspaveli
swedish orphan biovitrum ab (publ) - pegcetacoplan - hemoglobinuria, paroksysmal - leki immunosupresyjne - aspaveli is indicated in the treatment of adult patients with paroxysmal nocturnal haemoglobinuria (pnh) who are anaemic after treatment with a c5 inhibitor for at least 3 months.
azithromycin zim 500 mg tabletki powlekane
zim laboratories limited sia - azithromycinum dihydricum - tabletki powlekane - 500 mg
epysqli
samsung bioepis nl b.v. - Экулизумаб - hemoglobinuria, paroksysmal - leki immunosupresyjne - epysqli is indicated in adults and children for the treatment of paroxysmal nocturnal haemoglobinuria (pnh). evidence of clinical benefit is demonstrated in patients with haemolysis with clinical symptom(s) indicative of high disease activity, regardless of transfusion history.
broncho-vaxom 3,5 mg kapsułki twarde
omedicamed unipessoal lda - szczepionka wieloważna + galusan propylu (e310) + sodu glutaminian + mannitol - kapsułki twarde - 3,5 mg
broncho-vaxom 7 mg kapsułki twarde
omedicamed unipessoal lda - szczepionka wieloważna + galusan propylu (e310) + sodu glutaminian + mannitol - kapsułki twarde - 7 mg
broncho-vaxom dla dzieci 3,5 mg granulat w saszetce
omedicamed unipessoal lda - haemophilus influenzae + galusan propylu (e310) + sodu glutaminian + mannitol - granulat w saszetce - 3,5 mg
azibiot 500 mg tabletki powlekane
krka, d.d., novo mesto - azithromycinum - tabletki powlekane - 500 mg
floxamic 400 mg tabletki powlekane
zakłady farmaceutyczne polpharma s.a. - moxifloxacinum - tabletki powlekane - 400 mg
proxacin 1% 10 mg/ml koncentrat do sporządzania roztworu do infuzji
zentiva, k.s. - ciprofloxacinum - koncentrat do sporządzania roztworu do infuzji - 10 mg/ml